FRANCISCO JAVIER
MICHEL DE LA ROSA
Investigador hasta 2022
Hospital de Galdakao - Usansolo
Galdácano, EspañaPublicaciones en colaboración con investigadores/as de Hospital de Galdakao - Usansolo (2)
2023
-
First-Line Versus Second-Line Use of Reslizumab in Severe Uncontrolled Asthma
Journal of Investigational Allergology and Clinical Immunology
2018
-
Cost of hospitalizations due to exacerbation in patients with non-cystic fibrosis bronchiectasis
Respiration, Vol. 96, Núm. 5, pp. 406-416